(VIANEWS) – The NASDAQ opens in less than one hour and Illumina‘s pre-market value is already 5.49% up.
Illumina’s last close was $133.19, 44.17% under its 52-week high of $238.55.
The last session, NASDAQ finished with Illumina (ILMN) jumping 0.02% to $133.19. NASDAQ rose 1.25% to $16,369.41, after three sequential sessions in a row of gains, on what was an all-around positive trend exchanging session.
About Illumina
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Illumina has a trailing twelve months EPS of $-7.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.81%.
Sales Growth
Illumina’s sales growth is negative 3% for the present quarter and negative 4.3% for the next.
Moving Average
Illumina’s worth is below its 50-day moving average of $139.07 and way under its 200-day moving average of $150.24.
More news about Illumina (ILMN).
